Form D · Biotechnology
Matinas BioPharma Holdings, Inc.
Bedminster, NJ · CIK 0001582554
Offering snapshot reported Feb 19, 2025 · SEC filing
- Reported sold
- $1.65M Offering amount: $3.3M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 13, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 19, 2025 | Initial | $1,650,000 | No comparison | 4 | SEC filing |
| Jan 26, 2017 | Initial | $15,483,175 | No comparison | 270 | SEC filing |
| Aug 12, 2016 | Initial | $4,400,290 | No comparison | 34 | SEC filing |
| Apr 13, 2015 | Initial | $10,000,000 | No comparison | 122 | SEC filing |
| Aug 7, 2013 | Initial | $7,593,750 | No comparison | 52 | SEC filing |
| Jul 25, 2013 | Initial | $385,000 | No comparison | 31 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538675
Source: Form D, filed Feb 19, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Bobotas | Executive |
| Herbert Conrad | Director |
| Evelyn D'an | Director |
| Eric Ende | Director |
| Abdel A. Fawzy | Executive |
| Stefano Ferrari | Director |
| Gary Gaglione | Executive |
| Natasha Giordano | Director |
| Stephen P Harrington | Director, Executive |
| Jerome Jabbour | Director, Executive |
| Douglas F. Kling | Executive |
| Keith Kucinski | Executive |
| Raphael J. Mannino | Executive |
| Roelof Rongen | Director, Executive |
| James Scibetta | Director |
| Robin Smith | Director |
| Adam Stern | Director |
| Matthew Wikler | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1545 Route 206 South Suite 302
Bedminster, NJ, 07921
Bedminster, NJ, 07921